Very proud of our recent PGY1 pharmacy resident Kaylee Whitenack for getting this through to publication!
Much more to sort out, but albumin appears important for outcomes in MSSA bacteremia.
Small study, but super interesting findings! SNAP might provide more info!
🆕️✨️Impact of Hypoalbuminemia on Clinical Outcomes in Patients Receiving Cefazolin for MSSA Bacteremia #idxpostsjournals.sagepub.com/doi/abs…
A study led by Dr. @InfectiousDan Ilges, at Mayo Clinic Arizona found that excluding #Cdifficile from gastrointestinal pathogen panels reduced unnecessary treatments, improved diagnostic accuracy, and caused no delays in diagnosis.
Read more: contagionlive.com/view/exclu…
🆕️⚡️⚡️Quasi-experimental, pre/post, retrospective cohort
Positive impact of a diagnostic stewardship intervention
Following gastrointestinal pathogen panel C. difficile target removal, GIPP orders 🔽 from 3.23 to 2.7 per 1,000 patient visits (P < .001)
cambridge.org/core/journals/…
HIV viral load dropped 3.5 logs after 11 doses of Biktarvy per given per tube for patient on CRRT and ECMO. I told the team we’re crushing it. #twitterx
🆕️🔥Retrospective, multicenter, cohort study
Twice daily cephalexin is as effective as four times daily dosing for for the treatment of uncomplicated UTI with a cefazolin-susceptible urine culture #IDXpostsacademic.oup.com/ofid/articl…
🆕️🔥Retrospective, multicenter, cohort study
Twice daily cephalexin is as effective as four times daily dosing for for the treatment of uncomplicated UTI with a cefazolin-susceptible urine culture #IDXpostsacademic.oup.com/ofid/articl…
🆕️⚡️🔥Retrospective cohort study suggests that short (≤10 days) antimicrobial courses had comparable 90-day outcomes as intermediate and prolonged regimens for GN-BSI among immunocompromised patients with neutropenia #IDTwitter@IDdocAdi@BradSpellbergonlinelibrary.wiley.com/doi/…
With the latest CLSI breakpoints, tobramycin is the only reliable aminoglycoside for Pseudomonas if you ever need one (Susceptible: MIC ≤1)
Amikacin: can still be used for UTI (Susceptible: MIC ≤ 16)
Gentamicin: RIP ☠️
From @seausman, @MsSmallsO et al
Analysis of antimicrobial stewardship intervention acceptance rate at a multisite heath system showed female & male clinicians were equally effective at prospective audit and feedback
📄: doi.org/10.1017/ice.2023.93
Attention #IDtwitter - there’s still time to apply to our ID Rph clin specialist opening! Come work with our wonderful @MayoAZINFDIS team. Provide world-class care in beautiful AZ.
- cocci
- transplant
- stewardship
- research
- teaching
- and more!
fa-euwp-saasfaprod1.fa.ocs.o…
Congratulations Mayo clinic Arizona ID fellows- Leah Grant, Alexander Lietz and Jefferson Tobar Vega for presenting their research at Mayo Clinic Rochester on 4/21/2023.
Dr. Tobar Vega with Dr. Vikram, program director of ID fellowship.